Market Overview

Global Molecular Diagnostics Market by Technology, Application, Product, End-Users and Geography - Forecast to 2023 -


The "Global
Molecular Diagnostics Market - Segmented by Technology, Application,
Product, End-Users and Geography - Growth, Trends and Forecasts (2018 -
report has been added to's

The global molecular diagnostics market was estimated at around US$ 7
billion in 2017. The market is expected to register a CAGR of
approximately 9% during the forecast period, 2018 to 2023.

North America accounted for the largest market, followed by Europe, in
the molecular diagnostics market. Asia-Pacific was estimated to register
approximately 15% CAGR through the forecast period, 2018-2023.

Point-of-Care Diagnostics Demand

Near-patient and POC tests, currently, exist for a number of pathogens,
such as influenza, tuberculosis (TB), and other respiratory viruses,
such as Chlamydia, gonorrhea, and group A Streptococcus (GAS). These
include antigen tests (most commonly lateral-flow immunochromatographic
membrane-based assays and nucleic acid tests.

The POC tests are widely accepted because many tests are portable, fast,
fairly simple to use, and inexpensive. Along with other factors, such as
large outbreaks of bacterial and viral epidemics in the world, the
rapidly evolving technology is driving the molecular diagnostics market.

Notable Developments in the Market

  • Saudi Arabia announced the exemption of certain medications and
    medical equipment from the 5% VAT, which is scheduled to be
    implemented from January of 2018. Saudi Arabia is imposing VAT in
    coordination with other governments in the Gulf Cooperation Council as
    they seek new sources of revenue in a bid to close budget deficits
    caused by low oil prices.
  • Abbott completed acquisition of Alere Inc. It is a global manufacturer
    of rapid point-of-care diagnostic tests.
  • Agilent Technologies had acquired molecular and sample barcoding
    patent portfolios of Population Genetics Technologies.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Roche Diagnostics
  • Illumina Inc.
  • Hologic Corporation
  • Agilent Technologies/Dako
  • Qiagen
  • Myriad Genetics
  • BD (Becton, Dickinson & Company)
  • Abbott Laboratories
  • Cepheid Inc.
  • Genomic Health Inc.

10. Future of the Market

For more information about this report visit

View Comments and Join the Discussion!